Cleared Special

Carnation Ambulatory Monitor (CAM) (K210036) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K210036 · Bardy Diagnostics, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
30d
Days
Class 2
Risk

K210036 is an FDA 510(k) clearance for the Carnation Ambulatory Monitor (CAM). Classified as Recorder, Magnetic Tape, Medical (product code DSH), Class II - Special Controls.

Submitted by Bardy Diagnostics, Inc. (Seattle, US). The FDA issued a Cleared decision on February 5, 2021 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Bardy Diagnostics, Inc. devices

Submission Details

510(k) Number K210036 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 2021
Decision Date February 05, 2021
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DSH Recorder, Magnetic Tape, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSH Recorder, Magnetic Tape, Medical

All 34
Devices cleared under the same product code (DSH) and FDA review panel - the closest regulatory comparables to K210036.
LifeLens Wireless ECG Monitor
K203168 · LifeLens Technologies, Inc. · Jul 2021
Zio Monitor
K202359 · iRhythm Technologies, Inc. · May 2021
QardioCore
K201644 · Qardio, Inc. · Feb 2021
M5 Recorder
K202456 · Global Instrumentation, LLC · Dec 2020
Strados Remote Electronic Stethoscope Platform (RESP)
K201077 · Strados Labs · Dec 2020
Bioflux Software II
K201040 · Biotricity · Jul 2020